Impact of Recovery from Febrile Neutropenia on Intra-Individual Variability in Vancomycin Pharmacokinetics in Pediatric Patients
Background/Objectives: The pharmacokinetics of vancomycin (VCM) in patients with febrile neutropenia (FN) are highly variable due to coexisting conditions such as systemic inflammatory response syndrome and augmented renal clearance. Upon hematopoietic recovery, VCM clearance (CLvcm) is expected to...
Saved in:
Main Authors: | Yukie Takumi, Ryota Tanaka, Motoshi Iwao, Ryosuke Tatsuta, Hiroki Itoh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/14/6/570 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Febrile neutropenia due to H1N1 infection: Rare entity
by: Ayberk A. Besen, et al.
Published: (2016-01-01) -
Chemotherapy limiting neutropenia. Is prevention required?
by: I. B. Kononenko, et al.
Published: (2022-01-01) -
Optimal Primary Prophylaxis for Febrile Neutropenia During Neoadjuvant Cisplatin and 5‐Fluorouracil Plus Docetaxel for Esophageal Cancer: A Retrospective Cohort Study
by: Ryosuke Kumanishi, et al.
Published: (2025-05-01) -
Lipegfilgrastim in patients with chemotherapy-induced neutropenia
by: G. D. Petrova, et al.
Published: (2015-12-01) -
Chemotherapy-induced neutropenia and its determinants in patients with solid malignancies: A prospective observational study
by: Whitney Joseph J, et al.
Published: (2025-07-01)